# Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Gem with Nearly 80% Upside Potential

- Link: https://www.directorstalkinterviews.com/astrana-health-inc-asth-stock-analysis-a-healthcare-gem-with-nearly-80-upside-potential/4121241409
- Published: 2026-02-24T11:30:48+00:00
- Author: Madison Wilson

Astrana Health Inc. (NASDAQ: ASTH) stands out in the healthcare sector with a compelling
investment narrative, driven by its robust revenue growth and promising analyst 
ratings. As a medical care facilities company, Astrana Health is making significant
strides, offering a potential upside of nearly 80% based on current analyst price
targets. Here’s what investors need to know about this emerging healthcare player.

#### Company and Market Position

Astrana Health, headquartered in Alhambra, California, operates through three key
segments: Care Partners, Care Delivery, and Care Enablement. The company’s comprehensive
healthcare management services include care coordination for patients across various
insurance plans, as well as for non-insured patients. Founded in 1994, Astrana Health
has established a diverse physician network that caters to a broad spectrum of medical
needs.

With a current market capitalization of $994.08 million, Astrana Health is poised
for growth within the competitive U.S. healthcare market. Despite its relatively
modest market cap, the company is making waves with its innovative approach to healthcare
management.

#### Financial Performance and Valuation

Astrana Health’s recent financial performance is impressive, with revenue growth
surging by 99.70%. This indicates a strong market demand for its services and effective
business strategies. The company’s free cash flow stands at an impressive $208.4
million, which provides a solid foundation for future investments and potential 
expansion.

Despite the lack of a trailing P/E ratio, the forward P/E of 9.39 suggests that 
the stock is currently undervalued relative to its earnings potential. This is an
attractive metric for value-oriented investors seeking opportunities in the healthcare
sector.

#### Analyst Ratings and Price Targets

Investor sentiment around Astrana Health is predominantly positive, with nine buy
ratings and only two hold ratings. The stock’s average target price of $35.67 presents
a substantial potential upside of 79.95% from its current price of $19.82. The target
price range of $26.00 to $50.00 underscores the variability and potential within
Astrana Health’s future valuation, reflecting both cautious optimism and bullish
outlooks among analysts.

#### Technical Indicators

From a technical perspective, Astrana Health’s stock is currently trading below 
both its 50-day and 200-day moving averages, which are $23.62 and $26.11, respectively.
This trend suggests a possible undervaluation or a potential rebound opportunity
for investors. The Relative Strength Index (RSI) of 35.42 indicates that the stock
is nearing oversold territory, further supporting the case for a potential price
increase.

#### Growth and Investment Potential

Astrana Health’s unique positioning within the healthcare sector, combined with 
its significant revenue growth and solid free cash flow, makes it a compelling option
for investors. The absence of dividends and a payout ratio of 0.00% reflect the 
company’s focus on reinvestment and growth, rather than immediate shareholder returns.

For investors looking to capitalize on growth opportunities in the healthcare industry,
Astrana Health offers a promising proposition. Its nearly 80% potential upside, 
strong buy ratings, and robust financial performance provide a solid foundation 
for long-term investment consideration. As the company continues to expand and innovate
in healthcare management, it remains a stock to watch closely.

Share on: